A historic shift in Canadian drug policy has taken place, as the authorities permit the mushrooms recalled in Canada use of psilocybin fungi for therapeutic purposes. Previously, these substances were heavily restricted, but a increasing body of studies suggests they potentially offer aid for emotional illnesses like depression. This change represe